Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell surface components encompass a diverse array of structural molecules located on the exterior of bacteria, fungi, and viruses, including peptidoglycan, lipopolysaccharides (LPS), teichoic acids, and various surface proteins. These components are essential for maintaining the structural integrity of the microbe, facilitating adherence to host tissues, and mediating interactions with the external environment. In the context of human health, they serve as primary Pathogen-Associated Molecular Patterns (PAMPs) that are recognized by the innate immune system's Pattern Recognition Receptors (PRRs), such as Toll-like receptors, to trigger an inflammatory response. Many of the most effective antimicrobial therapies target these structures; for instance, beta-lactam antibiotics inhibit the cross-linking of peptidoglycan in bacterial cell walls, while polymyxins target the LPS of Gram-negative outer membranes. Because these components are often unique to microbes and absent in human cells, they represent high-selectivity targets for drug development, although the rapid evolution of these structures contributes significantly to the global challenge of antimicrobial resistance.
Drugs targeting these components typically act by inhibiting the biosynthesis of the cell wall (e.g., beta-lactams, glycopeptides), disrupting the integrity of the cytoplasmic or outer membrane (e.g., polymyxins, lipopeptides), or binding to specific surface molecules to neutralize their toxic effects or facilitate immune clearance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell surface components (MCSC).